Brief report · 29 Dec 2025
Research articlePublished 5 Mar 2022
Treatment Of Liver Cancer Using Specifically Targeted Plgabased Paclitaxel Nanoparticle
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We have designed a nanoparticle drug delivery system. The system included PLGA, paclitaxel (PTX) and transferrin (TF). This system can specifically target to liver cancer cells through intravenously administration. The PLGA-PTX-TF nanoparticles show excellent liver cancer treatment effect (IC50 4.79 g/mL) and are dose dependent in vitro. The PLGA-PTX-TF nanoparticle also show noticeable anti-tumor efficacy in vivo compared to PLGA-PTX (anti-cancer rate: 79.09% vs. 35.47%). Therefore, PLGA-PTX-TF nanoparticles can be considered as an effective anticancer drug delivery system for liver cancer therapy for the clinical use.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Oncology Medicine & Practice.
Brief report · 29 Dec 2025
Radiotherapy's Immune Microenvironment Shift Enhances Immunotherapy
Commentary · 29 Dec 2025
Novel Biomarker Panels for Early HCC Detection
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Oncology Medicine & Practice
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Ying Liu”
